tiprankstipranks
Advertisement

DTAN - ETF AI Analysis

Compare

Top Page

DTAN

Sparkline International Intangible Value ETF (DTAN)

Rating:66Neutral
Price Target:
DTAN, the Sparkline International Intangible Value ETF, appears to be a solid, well-rounded fund supported by high-quality global leaders like Novartis, Toyota, and AstraZeneca, which bring strong financial health, positive earnings calls, and good long-term business prospects. These strengths are slightly offset by valuation concerns and some mixed or short-term weak technical signals in several holdings such as Roche, Siemens Energy, and Hitachi. The main risk factor is that many top positions show signs of potential overvaluation or overbought conditions, which could increase volatility if market sentiment shifts.
Positive Factors
Broad International Diversification
The fund spreads its investments across many countries, including Japan, Germany, the U.S., and several others, which helps reduce the impact of problems in any single market.
Balanced Sector Mix
Holdings are spread across areas like consumer, health care, technology, and industrials, so the ETF is not overly tied to the fortunes of just one industry.
Several Strong Top Holdings
Some of the largest positions, such as Novartis, AstraZeneca, Shell, and Siemens Energy, have shown strong recent performance, supporting the fund’s overall returns.
Negative Factors
Moderately High Expense Ratio
The fund’s fee is on the higher side for an ETF, which can slowly eat into long-term returns compared with lower-cost options.
Small Asset Base
With relatively low assets under management, the ETF may be less liquid and more vulnerable to investor inflows and outflows than larger funds.
Mixed Performance Among Top Holdings
Several major positions, including Roche, Toyota, L’Oreal, and Sanofi, have shown weaker recent performance, which can drag on the fund’s results.

DTAN vs. SPDR S&P 500 ETF (SPY)

DTAN Summary

The Sparkline International Intangible Value ETF (DTAN) invests in companies around the world that are strong in “intangible” assets like brands, patents, and research, rather than just factories or real estate. It doesn’t track a specific index, but focuses on finding undervalued businesses in many countries, including Japan, Germany, and the U.S. Well-known holdings include Toyota and L’Oreal. Someone might invest in DTAN for international diversification and the potential growth of companies built on innovation and strong brands. A key risk is that its stock prices can go up and down with global markets and foreign currencies.
How much will it cost me?The Sparkline International Intangible Value ETF (DTAN) has an expense ratio of 0.55%, meaning you’ll pay $5.50 per year for every $1,000 invested. This is slightly higher than average because the fund is actively managed, focusing on companies with strong intangible assets, which requires more research and expertise.
What would affect this ETF?The Sparkline International Intangible Value ETF (DTAN) could benefit from global economic growth and increased demand for innovative companies leveraging intangible assets, such as intellectual property and brand strength, particularly in sectors like Health Care and Technology. However, it may face challenges from rising interest rates, which can impact the valuation of growth-focused companies, and geopolitical tensions or regulatory changes in the international markets where its top holdings, like Roche and Novartis, operate.

DTAN Top 10 Holdings

DTAN leans heavily on global healthcare champions, with Roche, Novartis, and AstraZeneca doing much of the heavy lifting as their shares have been generally rising or holding steady despite some recent bumps. Siemens and Siemens Energy add an industrial backbone, with both names climbing and giving the fund a bit of extra spark. On the flip side, consumer favorite L’Oreal and auto giant Toyota have been losing steam, acting as mild brakes on performance. Overall, the ETF is diversified across sectors but firmly anchored in non-U.S. markets.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Roche Holding AG3.46%$715.34K$336.41B30.82%
73
Outperform
Novartis AG3.15%$651.30KCHF215.09B25.30%
80
Outperform
Siemens2.79%$577.36K€205.66B26.32%
74
Outperform
Shell (UK)2.58%$533.29K£173.50B27.29%
73
Outperform
L'Oreal2.57%$531.74K€203.68B4.75%
71
Outperform
Toyota Motor2.52%$521.38K¥39.65T12.08%
80
Outperform
AstraZeneca2.51%$519.08K$287.95B28.75%
80
Outperform
Sanofi2.27%$469.32K€90.79B-12.33%
75
Outperform
Hitachi,Ltd.2.24%$463.82K¥23.36T16.01%
77
Outperform
Siemens Energy2.12%$438.48K€139.07B96.02%
72
Outperform

DTAN Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
31.52
Positive
100DMA
31.77
Positive
200DMA
30.90
Positive
Market Momentum
MACD
0.40
Negative
RSI
67.77
Neutral
STOCH
57.35
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DTAN, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 32.38, equal to the 50-day MA of 31.52, and equal to the 200-day MA of 30.90, indicating a bullish trend. The MACD of 0.40 indicates Negative momentum. The RSI at 67.77 is Neutral, neither overbought nor oversold. The STOCH value of 57.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DTAN.

DTAN Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$21.24M0.55%
66
Neutral
$45.33M1.09%
66
Neutral
$17.52M0.59%
57
Neutral
$17.11M0.54%
62
Neutral
$10.51M0.70%
59
Neutral
$9.04M0.60%
63
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DTAN
Sparkline International Intangible Value ETF
33.34
5.40
19.33%
AADR
AdvisorShares Dorsey Wright ADR ETF
ESIM
Eventide International ETF
ABLG
Abacus Fcf International Leaders Etf
PZIV
Pzena International Value ETF
VNIE
Vontobel International Equity Active ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement